This inventor holds 4 USPTO granted patents. Top assignees: Hangzhou Converd Co., Ltd., Hangzhou Converd Co., Ltd., Hangzhou Convero Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hangzhou, CN (2023)
- Zhejiang, CN (2023)
Company Filing History:
2 out of 8 
1 out of 1 
1 out of 1 Years Active: 2023-2026
Title: Jipo Sheng: Innovator in Cancer Treatment
Introduction
Jipo Sheng is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 4 patents, Sheng is recognized for his groundbreaking work in therapeutic agents and oncolytic adenoviruses.
Latest Patents
One of Jipo Sheng's latest patents is titled "Therapeutic agents comprising nucleic acids and TCR modified immune cells and uses thereof." This patent describes a therapeutic agent that includes a nucleic acid and a TCR modified immune cell. The agent aims to introduce a labeling polypeptide into tumor cells, enhancing the immune response against cancer. The therapeutic agent achieves a synergistic treatment effect, providing a new route for tumor treatment.
Another notable patent is "Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers." This patent presents a selectively replicating oncolytic adenovirus that integrates a coding sequence of exogenous shRNA to inhibit PDL1 expression in tumor cells. The oncolytic virus demonstrates a higher replication capability in tumor cells compared to normal primary cells, leading to a synergistic anti-tumor effect.
Career Highlights
Throughout his career, Jipo Sheng has worked with various companies, including Hangzhou Converd Co., Ltd. His innovative research has positioned him as a key figure in the development of advanced cancer therapies.
Collaborations
Jipo Sheng has collaborated with notable individuals in his field, including Fang Hu and Yafei Hou. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jipo Sheng's contributions to cancer treatment through his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic approaches to combat cancer effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile